litlas
Log inCreate account

Bruce A. Chabner

Active 1970–2023

Also published as
BRUCE A. CHABNER
90
Papers
18,582
Citations
77
h-index
90
i10-index

Citations

Citations per year for Bruce A. Chabner1973: 2 citations1974: 6 citations1975: 18 citations1976: 27 citations1977: 34 citations1978: 44 citations1979: 34 citations1980: 44 citations1981: 33 citations1982: 46 citations1983: 62 citations1984: 54 citations1985: 53 citations1986: 49 citations1987: 61 citations1988: 65 citations1989: 81 citations1990: 40 citations1991: 65 citations1992: 38 citations1993: 47 citations1994: 47 citations1995: 49 citations1996: 63 citations1997: 40 citations1998: 49 citations1999: 61 citations2000: 54 citations2001: 44 citations2002: 59 citations2003: 76 citations2004: 69 citations2005: 76 citations2006: 78 citations2007: 60 citations2008: 84 citations2009: 74 citations2010: 80 citations2011: 91 citations2012: 103 citations2013: 89 citations2014: 93 citations2015: 71 citations2016: 64 citations2017: 90 citations2018: 91 citations2019: 316 citations2020: 313 citations2021: 339 citations2022: 248 citations2023: 197 citations2024: 285 citations2025: 138 citations2026: 2 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,970 citing papers, 34.7% of this breakdownChina: 479 citing papers, 8.4% of this breakdownUnited Kingdom: 316 citing papers, 5.6% of this breakdownItaly: 240 citing papers, 4.2% of this breakdownCanada: 236 citing papers, 4.2% of this breakdownGermany: 206 citing papers, 3.6% of this breakdownFrance: 196 citing papers, 3.5% of this breakdownIndia: 155 citing papers, 2.7% of this breakdownNetherlands: 150 citing papers, 2.6% of this breakdownSpain: 137 citing papers, 2.4% of this breakdownJapan: 120 citing papers, 2.1% of this breakdownAustralia: 105 citing papers, 1.9% of this breakdown
0%34.7%Other 24.1%

Institutions

Fields

  • Medicine52.3%
  • Biochemistry, Genetics and Molecular Biology28.1%
  • Neuroscience3.7%
  • Materials Science2.6%
  • Engineering2.5%
  • Immunology and Microbiology2%
  • Other8.8%

Topics

  • Cancer Genomics and Diagnostics3.9%
  • Lymphoma Diagnosis and Treatment3.3%
  • Acute Lymphoblastic Leukemia research2.6%
  • Lung Cancer Treatments and Mutations1.6%
  • Viral-associated cancers and disorders1.4%
  • Epigenetics and DNA Methylation1.4%
  • Other85.8%

Coauthors

All papers

Open in search
  1. Chemotherapy and the war on cancer

    Authors: Bruce A. Chabner, Thomas G. Roberts - Nature reviews. Cancer 2005 cited by 2,107

  2. Application of Cell-Free DNA Analysis to Cancer Treatment

    Authors: Ryan B. Corcoran, Bruce A. Chabner - New England Journal of Medicine 2018 cited by 970

  3. Immune Checkpoint Inhibitors — The Need for Innovation

    Authors: P. Connor Johnson, Justin F. Gainor, Ryan J. Sullivan, Dan L. Longo, Bruce A. Chabner - New England Journal of Medicine 2023 cited by 49

  4. Histone Deacetylase Inhibitors in Cancer Therapy

    Authors: Andrew A. Lane, Bruce A. Chabner - Journal of Clinical Oncology 2009 cited by 872

  5. Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition

    Authors: Bob T. Li, Bobby Daly, Mary Gospodarowicz, Monica M. Bertagnolli, Otis W. Brawley, Bruce A. Chabner, Lola A. Fashoyin‐Aje, R. Angelo de Claro, Elizabeth Franklin, Jennifer S. Mills, Jeff Legos, Karen Kaucic, Mark Junjie Li, Lydia Thé, Tina Hou, Tinghui Wu, Björn Albrecht, Yi Shao, Justin Finnegan, Jing Qian, Javad Shahidi, Eduard Gasal, Craig Tendler, Geoffrey Kim, James Yan, Phuong K. Morrow, Charles S. Fuchs, Lianshan Zhang, Robert LaCaze, Stefan Oelrich, Martin J. Murphy, Richard Pazdur, Kevin Rudd, Yi‐Long Wu - Nature Medicine 2022 cited by 52

  6. HIV Infection and Survival Among Women With Cervical Cancer

    Authors: Scott Dryden‐Peterson, Memory Bvochora‐Nsingo, Gita Suneja, Jason A. Efstathiou, Surbhi Grover, Sebathu Chiyapo, Doreen Ramogola‐Masire, Malebogo Kebabonye-Pusoentsi, R.H. Clayman, Abigail C. Mapes, Neo Tapela, Aida Asmelash, Heluf Medhin, Akila N. Viswanathan, Anthony H. Russell, Lilie L. Lin, Mukendi Kayembe, Mompati Mmalane, Thomas C. Randall, Bruce A. Chabner, Shahin Lockman - Journal of Clinical Oncology 2016 cited by 207

  7. The Pharmacology and Clinical Use of Methotrexate

    Authors: Jacques Jolivet, Kenneth H. Cowan, Gregory A. Curt, Neil J. Clendeninn, Bruce A. Chabner - New England Journal of Medicine 1983 cited by 786

  8. Antibody–Drug Conjugates for the Treatment of Solid Tumors: Clinical Experience and Latest Developments

    Authors: Aiko Nagayama, Leif W. Ellisen, Bruce A. Chabner, Aditya Bardia - Targeted Oncology 2017 cited by 102

  9. Addressing the Financial Burden of Cancer Clinical Trial Participation: Longitudinal Effects of an Equity Intervention

    Authors: Ryan David Nipp, Hang Lee, Emily Gorton, Morgan RL Lichtenstein, Salome Kuchukhidze, Elyse R. Park, Bruce A. Chabner, Beverly Moy - The Oncologist 2019 cited by 79

  10. Design and clinical validation of a point-of-care device for the diagnosis of lymphoma via contrast-enhanced microholography and machine learning

    Authors: Hyungsoon Im, Divya Pathania, Philip J. McFarland, Aliyah R. Sohani, Ismail Degani, Matthew J. Allen, Benjamin Coble, Aoife Kilcoyne, Seonki Hong, Lucas Rohrer, Jeremy S. Abramson, Scott Dryden‐Peterson, Lioubov Fexon, Misha Pivovarov, Bruce A. Chabner, Hakho Lee, Cesar M. Castro, Ralph Weissleder - Nature Biomedical Engineering 2018 cited by 83

  11. Polyglutamation of methotrexate. Is methotrexate a prodrug?

    Authors: Bruce A. Chabner, Carmen J. Allegra, Gregory A. Curt, Neil J. Clendeninn, Jacob Baram, Satoshi Koizumi, J C Drake, Jacques Jolivet - Journal of Clinical Investigation 1985 cited by 467

  12. Rising Circulating Tumor DNA As a Molecular Biomarker of Early Disease Progression in Metastatic Breast Cancer

    Authors: Marko Velimirovic, Dejan Juric, Andrzej Niemierko, Laura M. Spring, Neelima Vidula, Seth A. Wander, Arielle J. Medford, Aparna R. Parikh, Giuliana Malvarosa, Megan Yuen, Ryan B. Corcoran, Beverly Moy, Steven J. Isakoff, Leif W. Ellisen, A. John Iafrate, Bruce A. Chabner, Aditya Bardia - JCO Precision Oncology 2020 cited by 24

  13. Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy

    Authors: Wyndham H. Wilson, Michael L. Grossbard, Stefania Pittaluga, Diane E. Cole, Deborah A. Pearson, Nicole Drbohlav, Seth M. Steinberg, Richard F. Little, John E. Janik, Martin Gutierrez, Mark Raffeld, Louis M. Staudt, Bruce D. Cheson, Dan L. Longo, Nancy L. Harris, Elaine S. Jaffe, Bruce A. Chabner, Robert E. Wittes, Frank M. Balis - Blood 2002 cited by 330

  14. Improving Prospects for Targeting RAS

    Authors: Harshabad Singh, Dan L. Longo, Bruce A. Chabner - Journal of Clinical Oncology 2015 cited by 110

  15. Financial Burden of Cancer Clinical Trial Participation and the Impact of a Cancer Care Equity Program

    Authors: Ryan David Nipp, Hang Lee, Elizabeth E. Powell, Nicole Birrer, Emily Poles, Daniel Finkelstein, Karen M. Winkfield, Sanja Percac‐Lima, Bruce A. Chabner, Beverly Moy - The Oncologist 2016 cited by 97

  16. NCI-60 Cell Line Screening: A Radical Departure in its Time

    Authors: Bruce A. Chabner - JNCI Journal of the National Cancer Institute 2016 cited by 86

  17. Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase.

    Authors: Edward Chu, David M. Koeller, John Casey, J C Drake, Bruce A. Chabner, Patrick C. Elwood, S Zinn, Carmen J. Allegra - National Academy of Sciences, Proceedings of the National Academy of Sciences 1991 cited by 385

  18. ERBB2 Inhibition and Heart Failure

    Authors: Gregory M. Coté, Douglas B. Sawyer, Bruce A. Chabner - New England Journal of Medicine 2012 cited by 101

  19. Use of Plasma Pharmacokinetics to Predict and Prevent Methotrexate Toxicity

    Authors: Ronald G. Stoller, Kenneth R. Hande, Samuel A. Jacobs, Steven A. Rosenberg, Bruce A. Chabner - New England Journal of Medicine 1977 cited by 400

  20. Concepts in use of high-dose methotrexate therapy

    Authors: Steven P. Treon, Bruce A. Chabner - Clinical Chemistry 1996 cited by 185

  21. Phase II trial of veliparib and temozolomide in metastatic breast cancer patients with and without BRCA1/2 mutations

    Authors: Jing Xu, Tanya E. Keenan, Beth Overmoyer, Nadine Tung, Rebecca Gelman, Karleen Habin, Judy E. Garber, Leif W. Ellisen, Eric P. Winer, Paul E. Goss, Beow Y. Yeap, Bruce A. Chabner, Steven J. Isakoff - Breast Cancer Research and Treatment 2021 cited by 22

  22. Inhibition of phosphoribosylaminoimidazolecarboxamide transformylase by methotrexate and dihydrofolic acid polyglutamates.

    Authors: Carmen J. Allegra, J C Drake, Jacques Jolivet, Bruce A. Chabner - National Academy of Sciences, Proceedings of the National Academy of Sciences 1985 cited by 313

  23. 7-Hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexate.

    Authors: Samuel A. Jacobs, Ronald G. Stoller, Bruce A. Chabner, D G Johns - Journal of Clinical Investigation 1976 cited by 256

  24. Advantages of a Truly Open-Access Data-Sharing Model

    Authors: Monica M. Bertagnolli, Oliver Sartor, Bruce A. Chabner, Mace L. Rothenberg, Sean Khozin, Charles Hugh-Jones, David Reese, Martin J. Murphy - New England Journal of Medicine 2017 cited by 95